Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
24.47
+0.20 (0.82%)
At close: Apr 28, 2026, 4:00 PM EDT
24.47
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Alto Neuroscience Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Alto Neuroscience stock have an average target of 29, with a low estimate of 10 and a high estimate of 50. The average target predicts an increase of 18.51% from the current stock price of 24.47.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Alto Neuroscience stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 7 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +22.60% | Apr 22, 2026 |
| Baird | Baird | Buy Maintains $41 → $38 | Buy | Maintains | $41 → $38 | +55.29% | Apr 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +104.33% | Apr 2, 2026 |
| Jones Trading | Jones Trading | Strong Buy Maintains $49 → $44 | Strong Buy | Maintains | $49 → $44 | +79.81% | Apr 2, 2026 |
| Wedbush | Wedbush | Hold Maintains $22 → $21 | Hold | Maintains | $22 → $21 | -14.18% | Apr 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.28
from -2.19
EPS Next Year
-2.78
from -2.28
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.86 | -2.26 | ||||||
| Avg | -2.28 | -2.78 | ||||||
| Low | -2.70 | -3.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.